Third Fiscal Quarter and Nine-Month Financial Trends: The Company's third fiscal quarter 2025 net earnings attributable to VPG stockholders was $7.8 million, or $0.59 per diluted share, compared to ...
Delivered Q3 2025 revenue of $83 millionQ32025 non-dermatologic revenue increased by 67% over Q32024Q32025 total test reports ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback